First-Line Protocol
What Is the Treatment for Eosinophilic Gastritis?
Eosinophilic gastritis (ICD-11 DA42.2, ICD-10 K52.8) requires targeted medical management. The structured first-line approach below is based on published clinical evidence.
Treatment Approach
The standard first-line management is based on systemic corticosteroid therapy, with prednisolone as the primary agent. Specific dosing, the tapering schedule, and treatment duration are detailed in the full protocol.
References
DOI: 10.3390/ijms242015165
- The standard therapy is based on systemic corticosteroids.
- Prednisolone (ranging from 30 mg/day to 40 mg/day, tapered gradually from 1 month to 3 months) has shown response rates ranging between 80% and 100% in patients not requiring surgical management.
View source ↗